Special Price 377.60 USD Product Information Product Name GLP-1 (7-37) peptide Documents Batch to batch variation of the purity Sequence Shortening H-HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG-OH Sequence H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH Length (aa) 31 Peptide Purity (HPLC) 95.73% Molecular Formula C 151 H 228 N 40 O 47 Molecular Weight 3355.65 Source Synthetic Form Powder Description GLP-1 (7-37) is an endogenous truncated form of GLP-1 that arises from proglucagon processing in intestinal endocrine L cells, GLP-1 (7-37) acts as a GLP-1 receptor agonist and is an insulinotropic hormone that augments glucose induced insulin secretion
PMID 38935778 Alhadeff AL et al
It is not licensed, not available on the NHS, and not available through legitimate UK pharmacies
Retatrutide is an investigational 39-amino-acid, fatty-acid-acylated triple agonist engineered to engage the GIP, GLP-1, and glucagon receptors from a single peptide backbone
What does a tirzepatide injection site reaction look like The first thing most people notice is redness
Such studies are inherently susceptible to confounding by socioeconomic status, access to healthcare, reimbursement policies, and patient adherence, all of which may significantly impact treatment continuation and metabolic outcomes